ΕMA Pediatric Committee, EPF, WDO, EAE Board Member

Hellenic Friedreich’s Ataxia Association, Legal Advisers, NATO Rapid Deployable Corps

Vice President, European Parliament

Minister of Health, Hellenic Ministry of Health

Director General, European Federation of Pharmaceutical Industries and Associations (EFPIA)

Chief Executive Officer, EURORDIS-Rare Diseases Europe

President “95” Rare Alliance Greece

Psychiatrist, Memember of the European Parliament

Executive Director, Thalassaemia International Federation (TIF)

Member of the BoD, EURORDIS, CEO of FEDER

Public Health Policy Director – Rare2030 Project Lead, EURORDIS-Rare Diseases Europe

Active Senior on Public Health for the European Commission

MD, DSc, Head of the National center for Cystic Fibrosis, Prague, Board Member of ESHG

Associate Professor at Vilnius University, Faculty of Medicine, Head of Unit

PhD Senior Policy officer- Research Programmes, DG Research and Innovation, European Commission

Member of the Board of Directors EURORDIS-Rare Diseases Europe, Chair of World Duchenne Organization

Board of Directors EURORDIS-Rare Diseases, UNIAMO, Member of the Council of National Alliances

Senior Director, Patient Advocacy Lead, Global Product Development, Pfizer Rare Disease

Department of Pediatrics and Adolescent Medicine, Medical University Vienna,

Chair, Future-Proofing Health Systems Committee, European Health Parliament, 7th edition

Minister for Labor and Social Affairs, Greece

MD, PhD, MA, Asst. Prof. of Paediatrics, Medical Faculty, University Medical Centre

MPH Chair of the Committee for Orphan Medicinal Products (COMP), European Medicines Agency (EMA)

EJP RD Coordinator, Assistant Director, INSERM, France

Secretary General, European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)

Scientific Administrator, Data Analytics and Methods Task Force, European Medicines Agency (EMA)

Public Affairs Director, EURORDIS-Rare Diseases Europe

Coordinator of the Orphanet Work Direct Grant and of the RD-CODE Project

President of the European Haemophilia Consortium (EHC)

Policy Officer, Unit B.3, DG Health and Food Safety, European Commission

Head of Government Affairs and Public Policy, EMEA & APAC, PTC Therapeutics

OCM Director – Regulatory Science Europe at Critical Path Institute (C-Path)

Founder & CEO, Data for Patients

Head of Advanced Therapies Human Medicines Division, European Medicines Agency (EMA)

Chair, Scientific Advice Working Party, EMA, Vice Chair EUnetHTA21, Senior Advisor NoMA

CEO, HCD Economics

Executive Director, Head of International Government Affairs and Policy, Alexion Pharmaceuticals

MEP, EPP Group in the European Parliament

Technical Officer, Medical Product Regulation at World Health Organization (WHO)

Senior Policy Officer, Thalassaemia International Federation (TIF)

Global Access & Healthcare Funding & Financing solutions lead, Roche

Managing Director of Vital Transformation

Professor, Finance, Director, Laboratory for Financial Engineering, MIT Sloan School of Management

CEO Apollo Therapeutics

PhD. Vice President NovaQuest Capital Management

Investment Officer, Growth Capital & Innovation Finance Unit, European Investment Bank (EIB)

Member of the European Parliament

MD, PhD Alternate Minister of Health, Ministry of Health, Greece

CeO IFET

General Manager of the Hellenic Association of Pharmaceutical Companies (SFEE)

Professor of Pathology-Rheumatology, Medical School, NKUA

General Manager, IQVIA Greece

Secretary General of Social Insurance, Ministry for Labor and Social Affairs

Associate Professor, Laboratory of Health Economics and Management, University of Piraeus

Senior Vice President Market Access and Pricing, Alira Health